Lataa...
Acetylcholinesterase inhibitor treatment for myasthenia gravis
BACKGROUND: In myasthenia gravis, antibody‐mediated blockade of acetylcholine receptors at the neuromuscular junction abolishes the naturally occurring ‘safety factor’ of synaptic transmission. Acetylcholinesterase inhibitors provide temporary symptomatic treatment of muscle weakness but there is co...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2014
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7390275/ https://ncbi.nlm.nih.gov/pubmed/25310725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006986.pub3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|